Ligand Pharmaceuticals Inc.
Symbol: LGND (NASDAQ)
186.60
▼ (-0.07%) -0.140
Company Description:
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Key Stats
- Today's Open: $186
- Today's High: $186.995
- Today's Low: $184.06
- Today's Volume: 14.97K
- Yesterday Close: $186.74
- Yesterday High: $187.76
- Yesterday Low: $181.49
- Yesterday Volume: 117.44K
- Last Min Volume: 24
- Last Min High: $186.608
- Last Min Low: $186.601
- Last Min VWAP: $186.608
Company Profile
- Name: Ligand Pharmaceuticals Inc.
- Website: https://www.ligand.com
- Listed Date: 1994-11-25
- Location: SAN DIEGO, CA
- Market Status: Active
- CIK Number: 0000886163
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $3.64B
- Round Lot: 100
- Outstanding Shares: 19.49M
- Asset Type: CS
RECENT FILINGS FOR LGND
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-17 | SCHEDULE 13G/A | View |
| 2025-10-03 | 4 | View |
| 2025-10-01 | 144 | View |
| 2025-09-24 | 4 | View |
| 2025-09-24 | 4 | View |
| 2025-09-23 | 144 | View |
| 2025-09-17 | 144 | View |
| 2025-09-16 | 8-K | View |
| 2025-09-04 | 4 | View |
| 2025-09-02 | 144 | View |
| 2025-08-14 | 8-K | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-12 | 4 | View |
| 2025-08-11 | 8-K | View |
| 2025-08-08 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-08-05 | 4 | View |
| 2025-08-01 | 144 | View |
| 2025-07-11 | 4 | View |
| 2025-07-10 | 144 | View |
Latest News on LGND